CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers.
Read More…
Industry, Sector and Symbol
Industry Freight transportation arrangement
Sub-IndustryN/A
SectorTransportation
Phone949-470-2300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$19.63 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date11/14/2019 (Estimated)
OptionableOptionable
CryoPort (NASDAQ:CYRX) Frequently Asked Questions
What is CryoPort's stock symbol?
CryoPort trades on the NASDAQ under the ticker symbol "CYRX."
How were CryoPort's earnings last quarter?
CryoPort Inc (NASDAQ:CYRX) released its earnings results on Thursday, August, 8th. The consumer goods maker reported ($0.08) EPS for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.08). The consumer goods maker earned $8.46 million during the quarter, compared to analysts' expectations of $7.94 million. CryoPort had a negative net margin of 35.71% and a negative return on equity of 17.32%. CryoPort's revenue for the quarter was up 82.7% on a year-over-year basis. During the same period in the previous year, the company earned ($0.09) EPS. View CryoPort's Earnings History.
When is CryoPort's next earnings date?
What price target have analysts set for CYRX?
4 analysts have issued 12 month price targets for CryoPort's shares. Their forecasts range from $22.00 to $26.00. On average, they anticipate CryoPort's share price to reach $24.00 in the next year. This suggests a possible upside of 35.9% from the stock's current price. View Analyst Price Targets for CryoPort.
What is the consensus analysts' recommendation for CryoPort?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CryoPort in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CryoPort.
Has CryoPort been receiving favorable news coverage?
News headlines about CYRX stock have been trending somewhat negative this week, InfoTrie reports. The research group ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CryoPort earned a coverage optimism score of -1.3 on InfoTrie's scale. They also assigned headlines about the consumer goods maker a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for CryoPort.
Who are some of CryoPort's key competitors?
What other stocks do shareholders of CryoPort own?
Who are CryoPort's key executives?
CryoPort's management team includes the folowing people:
- Jerrell W. Shelton, Chairman, President & Chief Executive Officer
- Phil Wilson, SVP-Global Operations & Supply Chain
- Robert S. Stefanovich, Chief Financial Officer, Secretary & Treasurer
- Bret Bollinger, Chief Technology Officer
- Mark W. Sawicki, Chief Commercial Officer
Who are CryoPort's major shareholders?
CryoPort's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (5.76%), Vanguard Group Inc. (5.49%), Victory Capital Management Inc. (3.33%), Invesco Ltd. (3.13%), Price T Rowe Associates Inc. MD (1.97%) and Creative Planning (1.74%). Company insiders that own CryoPort stock include Jerrell Shelton and Richard J Berman. View Institutional Ownership Trends for CryoPort.
Which institutional investors are selling CryoPort stock?
CYRX stock was sold by a variety of institutional investors in the last quarter, including Creative Planning, Rice Hall James & Associates LLC, Allianz Asset Management GmbH, D.A. Davidson & CO., FNY Investment Advisers LLC, Conestoga Capital Advisors LLC, Premier Asset Management LLC and Zurcher Kantonalbank Zurich Cantonalbank. View Insider Buying and Selling for CryoPort.
Which institutional investors are buying CryoPort stock?
CYRX stock was acquired by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Invesco Ltd., Price T Rowe Associates Inc. MD, Cortina Asset Management LLC, Vanguard Group Inc., River & Mercantile Asset Management LLP, River & Mercantile Asset Management LLP and Handelsbanken Fonder AB. View Insider Buying and Selling for CryoPort.
How do I buy shares of CryoPort?
Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is CryoPort's stock price today?
One share of CYRX stock can currently be purchased for approximately $17.66.
How big of a company is CryoPort?
CryoPort has a market capitalization of $628.52 million and generates $19.63 million in revenue each year. The consumer goods maker earns $-9,560,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. View Additional Information About CryoPort.
What is CryoPort's official website?
How can I contact CryoPort?
CryoPort's mailing address is 17305 DAIMLER STREET, IRVINE CA, 92614. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]
MarketBeat Community Rating for CryoPort (NASDAQ CYRX)
MarketBeat's community ratings are surveys of what our community members think about CryoPort and other stocks. Vote "Outperform" if you believe CYRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
